BCAB
Bioatla IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.89M
P/E Ratio
—
EPS
$-25.46
Beta
0.70
52W High
$71.50
52W Low
$1.07
50-Day MA
$3.34
200-Day MA
$12.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bioatla Inc
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $8.50M |
| Gross Profit (TTM) | $-16.06M |
| EBITDA | $-30.83M |
| Operating Margin | 3.49% |
| Return on Equity | -814.00% |
| Return on Assets | -105.90% |
| Revenue/Share (TTM) | $6.14 |
| Book Value | $-21.79 |
| Price-to-Book | 37.67 |
| Price-to-Sales (TTM) | 0.34 |
| EV/Revenue | 0.744 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.60% |
| Shares Outstanding | $1.67M |
| Float | $1.38M |
| % Insiders | 5.41% |
| % Institutions | 21.37% |
Historical Volatility
HV 10-Day
69.71%
HV 20-Day
54.95%
HV 30-Day
63.29%
HV 60-Day
76.91%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCAB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026